Cash & equivalents increased 489.7%
Cash & equivalents changed +489.7% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed +489.7% from the comparable as-filed period.
Gross profit changed +630.1% from the comparable as-filed period.
Inventory changed +1261.9% from the comparable as-filed period.
Operating margin changed +29169 basis points from the comparable as-filed period.
Research & development changed +586.7% from the comparable as-filed period.
Revenue changed +687.3% from the comparable as-filed period.
Gross margin changed -272 basis points from the comparable as-filed period.
Net income changed -11.8% from the comparable as-filed period.
Operating income changed -9.0% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.